TY - JOUR
T1 - Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) Randomized Controlled Trials
AU - Sotomi, Yohei
AU - Onuma, Yoshinobu
AU - Cavalcante, Rafael
AU - Ahn, Jung-Min
AU - Lee, Cheol Whan
AU - van Klaveren, David
AU - de Winter, Robbert J.
AU - Wykrzykowska, Joanna J.
AU - Farooq, Vasim
AU - Morice, Marie-Claude
AU - Steyerberg, Ewout W.
AU - Park, Seung-Jung
AU - Serruys, Patrick W.
PY - 2017
Y1 - 2017
N2 - The impact of sex on clinical outcomes of percutaneous coronary intervention and coronary artery bypass graft for patients with multivessel coronary disease and unprotected left main disease could be dissimilar between Western and Asian populations. 2=58%). The present meta-analysis suggested the presence of the heterogeneous sex-treatment interaction across Asian and Western trials. Considering the ongoing globalization of our medical practice, the heterogeneity of the sex-treatment interaction needs to be well recognized and taken into account during the decision making of the treatment strategy. URL: https://www.clinicaltrials.gov. Unique identifiers: NCT00114972, NCT00997828, NCT00422968
AB - The impact of sex on clinical outcomes of percutaneous coronary intervention and coronary artery bypass graft for patients with multivessel coronary disease and unprotected left main disease could be dissimilar between Western and Asian populations. 2=58%). The present meta-analysis suggested the presence of the heterogeneous sex-treatment interaction across Asian and Western trials. Considering the ongoing globalization of our medical practice, the heterogeneity of the sex-treatment interaction needs to be well recognized and taken into account during the decision making of the treatment strategy. URL: https://www.clinicaltrials.gov. Unique identifiers: NCT00114972, NCT00997828, NCT00422968
U2 - https://doi.org/10.1161/CIRCINTERVENTIONS.117.005027
DO - https://doi.org/10.1161/CIRCINTERVENTIONS.117.005027
M3 - Article
C2 - 28495897
SN - 1941-7640
VL - 10
JO - Circulation. Cardiovascular interventions
JF - Circulation. Cardiovascular interventions
IS - 5
M1 - e005027
ER -